Bollard Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20	Closed	-$7K	–	650
2023 Q2	$7K	Buy	+20	New	+$7K	﹤0.01%	356
2013 Q4	–	Sell	-1,280	Closed	-$97K	–	262
2013 Q3	$97K	Buy	+1,280	New	+$97K	0.01%	204